Latest Insider Transactions at Maravai Lifesciences Holdings, Inc. (MRVI)
This section provides a real-time view of insider transactions for Maravai Lifesciences Holdings, Inc. (MRVI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARAVAI LIFESCIENCES HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARAVAI LIFESCIENCES HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2023
|
Constantine S Mihas Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+45.91%
|
-
|
|
Jul 17
2023
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+28.53%
|
-
|
|
Jul 17
2023
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+30.33%
|
-
|
|
Apr 28
2023
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,920
+1.37%
|
$21,120
$11.72 P/Share
|
|
Apr 28
2023
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,394
+1.85%
|
$15,334
$11.72 P/Share
|
|
Apr 28
2023
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,014
+1.57%
|
$11,154
$11.72 P/Share
|
|
Apr 28
2023
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
874
+0.94%
|
$9,614
$11.72 P/Share
|
|
Mar 15
2023
|
Carl Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
147,638
+40.21%
|
-
|
|
Mar 15
2023
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
55,775
+43.45%
|
-
|
|
Mar 15
2023
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,507
+44.29%
|
-
|
|
Mar 15
2023
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,507
+34.77%
|
-
|
|
Mar 15
2023
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
38,386
+38.1%
|
-
|
|
Feb 15
2023
|
Christine Dolan Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,956
-10.41%
|
$29,340
$15.23 P/Share
|
|
Feb 15
2023
|
Kurt Oreshack General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-8.8%
|
$34,680
$15.23 P/Share
|
|
Feb 15
2023
|
Kevin Herde Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,611
-12.26%
|
$39,165
$15.23 P/Share
|
|
Feb 15
2023
|
Carl Hull Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,719
-11.91%
|
$145,785
$15.23 P/Share
|
|
Feb 15
2023
|
Brian Neel Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,312
-12.31%
|
$34,680
$15.23 P/Share
|
|
Jan 22
2023
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,575,170
-3.7%
|
-
|
|
Oct 31
2022
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
351
+1.32%
|
$4,914
$14.11 P/Share
|
|
Oct 31
2022
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
478
+2.2%
|
$6,692
$14.11 P/Share
|
|
Oct 31
2022
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
329
+1.72%
|
$4,606
$14.11 P/Share
|
|
Oct 17
2022
|
William E. Martin Iii Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
348,055
+44.79%
|
-
|
|
Jul 15
2022
|
Peter Michael Leddy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
63,498
+50.0%
|
-
|
|
Apr 29
2022
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
572
+3.01%
|
$12,584
$22.95 P/Share
|
|
Apr 29
2022
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
427
+2.01%
|
$9,394
$22.95 P/Share
|
|
Apr 29
2022
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
666
+3.42%
|
$14,652
$22.95 P/Share
|
|
Apr 29
2022
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
394
+1.5%
|
$8,668
$22.95 P/Share
|
|
Jan 28
2022
|
Murali Prahalad Director |
SELL
Bona fide gift
|
Direct |
13,300
-14.42%
|
-
|
|
Jan 25
2022
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+48.41%
|
-
|
|
Jan 25
2022
|
Carl Hull Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,600
+50.0%
|
-
|
|
Jan 25
2022
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+39.97%
|
-
|
|
Jan 25
2022
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,000
+48.73%
|
-
|
|
Jan 25
2022
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+48.89%
|
-
|
|
Dec 31
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,570,415
-2.04%
|
-
|
|
Nov 19
2021
|
Sean Laurence Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Gregory T Lucier Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+12.07%
|
-
|
|
Nov 19
2021
|
Luke Joseph Marker Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Benjamin James Daverman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Anat Ashkenazi Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+20.94%
|
-
|
|
Nov 19
2021
|
Constantine S Mihas Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+50.0%
|
-
|
|
Nov 19
2021
|
Susannah Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+10.57%
|
-
|
|
Nov 19
2021
|
Robert B Hance Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+14.05%
|
-
|
|
Nov 19
2021
|
Jessica Hopfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+6.07%
|
-
|
|
Nov 19
2021
|
Murali Prahalad Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,271
+11.12%
|
-
|
|
Oct 31
2021
|
Christine Dolan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
203
+15.36%
|
$4,466
$22.95 P/Share
|
|
Oct 31
2021
|
Kurt Oreshack General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
542
+5.97%
|
$11,924
$22.95 P/Share
|
|
Oct 31
2021
|
Brian Neel Officer |
BUY
Grant, award, or other acquisition
|
Direct |
598
+40.35%
|
$13,156
$22.95 P/Share
|
|
Oct 31
2021
|
Kevin Herde Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
392
+30.6%
|
$8,624
$22.95 P/Share
|
|
Sep 09
2021
|
Gtcr Investment Xi LLC |
SELL
Other acquisition or disposition
|
Indirect |
17,068,559
-11.91%
|
-
|
|
Sep 09
2021
|
Gtcr Investment Xi LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,931,441
-11.91%
|
$146,572,050
$50.0 P/Share
|